Gain Therapeutics, Inc. ( GANX) - Key Metrics
GANX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.11 | -$0.11 | -$0.11 |
| 2026Q1 | $0 | -$0.13 | -$0.11 | -$0.11 |
| 2025Q4 | $0 | -$0.14 | -$0.14 | -$0.14 |
| 2025Q3 | $0 | -$0.15 | -$0.14 | -$0.14 |
| 2025Q2 | $0 | -$0.19 | -$0.17 | -$0.17 |
GANX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.61 |
| 2026Q1 | 0% | -3.73 |
| 2025Q4 | 0% | -7.32 |
| 2025Q3 | 0% | -2.95 |
| 2025Q2 | 0% | -2.37 |
GANX
Price: $2.03
52 week price:
Earnings Per Share: -0.50 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 17900
Market Capitalization: 90.4 million